DOSEF
Price
$1.00
Change
-$0.02 (-1.96%)
Updated
Aug 14 closing price
Capitalization
3.93M
Intraday BUY SELL Signals
SGMT
Price
$7.86
Change
+$0.04 (+0.51%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
254.64M
Intraday BUY SELL Signals
Interact to see
Advertisement

DOSEF vs SGMT

Header iconDOSEF vs SGMT Comparison
Open Charts DOSEF vs SGMTBanner chart's image
Doseology Sciences
Price$1.00
Change-$0.02 (-1.96%)
Volume$1.86K
Capitalization3.93M
Sagimet Biosciences
Price$7.86
Change+$0.04 (+0.51%)
Volume$9.12K
Capitalization254.64M
DOSEF vs SGMT Comparison Chart in %
DOSEF
Daily Signal:
Gain/Loss:
SGMT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DOSEF vs. SGMT commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DOSEF is a Hold and SGMT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (DOSEF: $1.00 vs. SGMT: $7.83)
Brand notoriety: DOSEF and SGMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DOSEF: 100% vs. SGMT: 62%
Market capitalization -- DOSEF: $3.95M vs. SGMT: $255.62M
DOSEF [@Biotechnology] is valued at $3.95M. SGMT’s [@Biotechnology] market capitalization is $255.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DOSEF’s FA Score shows that 0 FA rating(s) are green whileSGMT’s FA Score has 0 green FA rating(s).

  • DOSEF’s FA Score: 0 green, 5 red.
  • SGMT’s FA Score: 0 green, 5 red.
According to our system of comparison, SGMT is a better buy in the long-term than DOSEF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DOSEF’s TA Score shows that 2 TA indicator(s) are bullish while SGMT’s TA Score has 5 bullish TA indicator(s).

  • DOSEF’s TA Score: 2 bullish, 0 bearish.
  • SGMT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DOSEF is a better buy in the short-term than SGMT.

Price Growth

DOSEF (@Biotechnology) experienced а 0.00% price change this week, while SGMT (@Biotechnology) price change was -7.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGMT($255M) has a higher market cap than DOSEF($3.93M). DOSEF YTD gains are higher at: 611.744 vs. SGMT (74.000). DOSEF has higher annual earnings (EBITDA): -296.52K vs. SGMT (-66.89M). SGMT has more cash in the bank: 125M vs. DOSEF (820K). DOSEF has less debt than SGMT: DOSEF (0) vs SGMT (152K). DOSEF has higher revenues than SGMT: DOSEF (46.7K) vs SGMT (0).
DOSEFSGMTDOSEF / SGMT
Capitalization3.93M255M2%
EBITDA-296.52K-66.89M0%
Gain YTD611.74474.000827%
P/E RatioN/AN/A-
Revenue46.7K0-
Total Cash820K125M1%
Total Debt0152K-
TECHNICAL ANALYSIS
Technical Analysis
DOSEFSGMT
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
Declines
ODDS (%)
N/A
Bearish Trend 13 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
DOSEF
Daily Signal:
Gain/Loss:
SGMT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTOR1.300.08
+6.56%
Citius Oncology Inc
BWMN33.660.09
+0.27%
Bowman Consulting Group Ltd
WAFU1.70-0.01
-0.58%
Wah Fu Education Group Limited
CWT45.00-0.47
-1.03%
California Water Service
GWRE214.33-2.42
-1.12%
Guidewire Software

DOSEF and

Correlation & Price change

A.I.dvisor tells us that DOSEF and MNPR have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DOSEF and MNPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DOSEF
1D Price
Change %
DOSEF100%
N/A
MNPR - DOSEF
24%
Poorly correlated
+5.46%
AKRO - DOSEF
23%
Poorly correlated
-0.05%
SGMT - DOSEF
21%
Poorly correlated
+0.26%
ADAG - DOSEF
21%
Poorly correlated
+9.12%
CLRPF - DOSEF
12%
Poorly correlated
N/A
More

SGMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMT has been loosely correlated with CUE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMT jumps, then CUE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMT
1D Price
Change %
SGMT100%
+0.26%
CUE - SGMT
44%
Loosely correlated
+2.28%
SYRE - SGMT
39%
Loosely correlated
-1.07%
OCUL - SGMT
37%
Loosely correlated
-1.09%
CRBU - SGMT
36%
Loosely correlated
-0.79%
XENE - SGMT
36%
Loosely correlated
N/A
More